BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 20360470)

  • 21. The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions.
    Rieux-Laucat F; Magérus-Chatinet A; Neven B
    J Clin Immunol; 2018 Jul; 38(5):558-568. PubMed ID: 29911256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.
    Aspinall AI; Pinto A; Auer IA; Bridges P; Luider J; Dimnik L; Patel KD; Jorgenson K; Woodman RC
    Blood Cells Mol Dis; 1999; 25(3-4):227-38. PubMed ID: 10575548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies.
    Consonni F; Gambineri E; Favre C
    Ann Hematol; 2022 Mar; 101(3):469-484. PubMed ID: 35059842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation.
    Xie Y; Pittaluga S; Price S; Raffeld M; Hahn J; Jaffe ES; Rao VK; Maric I
    Haematologica; 2017 Feb; 102(2):364-372. PubMed ID: 27846610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease.
    Nabhani S; Ginzel S; Miskin H; Revel-Vilk S; Harlev D; Fleckenstein B; Hönscheid A; Oommen PT; Kuhlen M; Thiele R; Laws HJ; Borkhardt A; Stepensky P; Fischer U
    Haematologica; 2015 Sep; 100(9):1189-98. PubMed ID: 26113417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The contribution of rare copy number variants in FAS toward pathogenesis of autoimmune lymphoproliferative syndrome.
    Jevtich K; Price S; Similuk M; Kulm E; Yan J; Setzer M; Jamal L; Franco LM; Ghosh R; Walkiewicz M; Rao VK
    Blood Adv; 2022 Jul; 6(13):3974-3978. PubMed ID: 35476126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of the potential role of CASPASE-10 mutations in the development of autoimmune lymphoproliferative syndrome.
    Consonni F; Moreno S; Vinuales Colell B; Stolzenberg MC; Fernandes A; Parisot M; Masson C; Neveux N; Rosain J; Bamberger S; Vigue MG; Malphettes M; Quartier P; Picard C; Rieux-Laucat F; Magerus A
    Cell Death Dis; 2024 May; 15(5):315. PubMed ID: 38704374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell Proliferation.
    Mazerolles F; Stolzenberg MC; Pelle O; Picard C; Neven B; Fischer A; Magerus-Chatinet A; Rieux-Laucat F
    Front Immunol; 2018; 9():718. PubMed ID: 29686686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel insights into FAS defects underlying autoimmune lymphoproliferative syndrome revealed by studies in consanguineous patients.
    Ben-Mustapha I; Agrebi N; Barbouche MR
    J Leukoc Biol; 2018 Mar; 103(3):501-508. PubMed ID: 29345341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome.
    Kuehn HS; Caminha I; Niemela JE; Rao VK; Davis J; Fleisher TA; Oliveira JB
    J Immunol; 2011 May; 186(10):6035-43. PubMed ID: 21490157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome.
    Caminha I; Fleisher TA; Hornung RL; Dale JK; Niemela JE; Price S; Davis J; Perkins K; Dowdell KC; Brown MR; Rao VK; Oliveira JB
    J Allergy Clin Immunol; 2010 Apr; 125(4):946-949.e6. PubMed ID: 20227752
    [No Abstract]   [Full Text] [Related]  

  • 32. Somatic loss of heterozygosity, but not haploinsufficiency alone, leads to full-blown autoimmune lymphoproliferative syndrome in 1 of 12 family members with FAS start codon mutation.
    Hauck F; Magerus-Chatinet A; Vicca S; Rensing-Ehl A; Roesen-Wolff A; Roesler J; Rieux-Laucat F
    Clin Immunol; 2013 Apr; 147(1):61-68. PubMed ID: 23524443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of lymphoma in Autoimmune Lymphoproliferative Syndrome (ALPS) and its relationship to Fas gene mutations.
    Poppema S; Maggio E; van den Berg A
    Leuk Lymphoma; 2004 Mar; 45(3):423-31. PubMed ID: 15160902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of autoimmune lymphoproliferative syndrome caused by FAS deficiency in adults.
    Lambotte O; Neven B; Galicier L; Magerus-Chatinet A; Schleinitz N; Hermine O; Meyts I; Picard C; Godeau B; Fischer A; Rieux-Laucat F
    Haematologica; 2013 Mar; 98(3):389-92. PubMed ID: 22983577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma.
    Kaya Z; Işık M; Oruklu N; Kirkiz S; Bağrıaçık EÜ; Allende LM; Díaz-Madroñero MJ; Ruiz-García R; Pınarlı FG; Göçün Uyar P; Koçak Ü
    Turk J Haematol; 2021 Jun; 38(2):145-150. PubMed ID: 33375216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune lymphoproliferative syndrome: an update and review of the literature.
    Shah S; Wu E; Rao VK; Tarrant TK
    Curr Allergy Asthma Rep; 2014 Sep; 14(9):462. PubMed ID: 25086580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disturbed B-lymphocyte selection in autoimmune lymphoproliferative syndrome.
    Janda A; Schwarz K; van der Burg M; Vach W; Ijspeert H; Lorenz MR; Elgizouli M; Pieper K; Fisch P; Hagel J; Lorenzetti R; Seidl M; Roesler J; Hauck F; Traggiai E; Speckmann C; Rensing-Ehl A; Ehl S; Eibel H; Rizzi M
    Blood; 2016 May; 127(18):2193-202. PubMed ID: 26907631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-10/Janus kinase/signal transducer and activator of transcription 3 signaling dysregulates Bim expression in autoimmune lymphoproliferative syndrome.
    Niss O; Sholl A; Bleesing JJ; Hildeman DA
    J Allergy Clin Immunol; 2015 Mar; 135(3):762-70. PubMed ID: 25174872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in autoimmune lymphoproliferative syndromes.
    Madkaikar M; Mhatre S; Gupta M; Ghosh K
    Eur J Haematol; 2011 Jul; 87(1):1-9. PubMed ID: 21447005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The genetic landscape of the FAS pathway deficiencies.
    Magerus A; Bercher-Brayer C; Rieux-Laucat F
    Biomed J; 2021 Aug; 44(4):388-399. PubMed ID: 34171534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.